No Superiority of Treatment With Osmotic Controlled-Release Oral Delivery System–Methylphenidate Over Short/Medium-Acting Methylphenidate Preparations in the …
Objectives Methylphenidate (MPH) treatment in patients with attention-deficit/hyperactivity
disorder (ADHD) is reported to reduce the risk for injuries. In the present study, the rate and
timing of injuries were compared among the various MPH preparations (4 and 6–8 vs 12
hour-acting) in children with ADHD. Methods This real-world retrospective study covered the
years 2011 to 2013. Participants included 2042 youngsters (aged 4–18 years, 13.01±3.2
years; 71.8% males and 28.2% females) diagnosed with ADHD according to the …
disorder (ADHD) is reported to reduce the risk for injuries. In the present study, the rate and
timing of injuries were compared among the various MPH preparations (4 and 6–8 vs 12
hour-acting) in children with ADHD. Methods This real-world retrospective study covered the
years 2011 to 2013. Participants included 2042 youngsters (aged 4–18 years, 13.01±3.2
years; 71.8% males and 28.2% females) diagnosed with ADHD according to the …
以上显示的是最相近的搜索结果。 查看全部搜索结果